Solutions: Clinical Trials

57 trials of Solutions, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

57 completed. 57 Phase 3, 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 357Completed 57
Phase 27Completed 7

Follow Solutions: new trials by email Literature Review of Solutions trials Research Report on Solutions

Trials (filtered) newest first · largest first

All 57 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases
TAK-881, HYQVIA - Primary Immunodeficiency Diseases (PID)
Phase 2 / Phase 3CompletedTakeda652023-10-242026-09-30
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)
Clascoterone 5% solution, Vehicle solution - Alopecia, Androgenetic
Phase 3CompletedCassiopea SpA7622023-08-172025-12-22
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
Clascoterone 5% solution, Vehicle solution - Alopecia, Androgenetic
Phase 3CompletedCassiopea SpA7032023-06-212026-06-08
Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men
Minoxidil 5% Topical Solution, microneedling - Androgenetic Alopecia
Phase 3CompletedUniversitas Indonesia362023-06-012023-09-28
Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults
Intravenous immunoglobulin (IVIG), 10% solution for infusion - Primary Immune Thrombocytopenia
Phase 3CompletedBiopharma Plasma LLC322022-07-262024-09-23
HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial
Haldol 2mg/ml oral solution, Olanzapine Actavis 5mg orodispersible tablet - Haloperidol, Advanced Cancer
Phase 3CompletedTan Tock Seng Hospital222022-05-182026-10-05
Comparison of Fluid Resuscitation in Pediatric Burn Patients Using Crystalloids and With Albumin on Day Two.
5% Albumin (human) Solution, Paeds solution - Burns
Phase 2 / Phase 3CompletedKing Edward Medical University902022-01-012024-01-25
Efficacy and Safety Study of Ketorolac / Pitofenone / Fenpiverinium for the Treatment of Patients With Pain After Surgical Abdominal and Pelvic Operations
Ketorolac tromethamine, solution for injection then Neospastil, film-coated tablets, Ketorolac tromethamine, solution for injection then Ketorolac tromethamine, coated tablets, Neospastil, solution for injection then Neospastil, film-coated tablets - Postsurgical Pain
Phase 2 / Phase 3CompletedDarnitsa Pharmaceutical Company4242021-07-072022-11-07
Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Otic Solution in the Treatment of Acute Otitis Externa
Ciprofloxacin-Fluocinolone Acetonide, 0.3%-0.025% Otic Solution, Ciprofloxacin 0.3% solution - Acute Otitis Externa
Phase 3CompletedLee's Pharmaceutical Limited6002021-01-042026-10-13
Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19
EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19), Placebo (sodium chloride, a 0.9% solution for the preparation of dosage forms for injections) - COVID-19
Phase 3CompletedFederal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"30002020-11-272022-03-16
The Effect of Perioperative Dexamethasone Administration on Postoperative Pain in Patients Undergoing Periacetabular Osteotomy.
Dexamethasone 24mg Solution for Injection, Saline Solution for Injection - Dexamethasone, Hip Dysplasia
Phase 2 / Phase 3CompletedOdense University Hospital902020-11-122024-04-02
A Study of Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)
Immune Globulin Intravenous (IGIV), Immune Globulin Subcutaneous, 20% Solution (IGSC, 20%) - Primary Immunodeficiency Diseases (PID)
Phase 3CompletedBaxalta now part of Shire172020-08-112024-03-22
Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhage
Milrinone 1 Mg/mL Solution for Injection, Saline solution for injection - Vasospasm
Phase 3CompletedUniversity Hospital, Angers3702020-08-102026-03-09
The Effect of Vitamin D Supplementation on COVID-19 Recovery
Vit-D 0.2 MG/ML Oral Solution [Calcidol], Physiological Irrigating Solution - Covid19
Phase 3CompletedUniversity of Monastir1302020-04-222021-05-12
Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)
MENOPUR solution for injection in pre-filled pen, 1200 IU/1.92 mL, MENOPUR powder and solvent for solution for injection, 75 IU, Placebo (for MENOPUR solution for injection in pre-filled pen) - Infertility
Phase 3CompletedFerring Pharmaceuticals4052019-10-252023-11-07
Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
gadopiclenol, Gadobutrol 1Mmol/mL Solution for Injection Vial - CNS Lesion, Blood Brain Barrier Defect
Phase 3CompletedGuerbet2602019-06-032025-09-22
A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia
Topical SM04554 0.15% solution, Topical SM04554 0.25% solution, Topical vehicle solution - Androgenetic Alopecia
Phase 2 / Phase 3CompletedBiosplice Therapeutics, Inc.6752018-11-012026-10-01
Antibacterial Effect of Nano Silver Fluoride vs Chlorhexidine on Occlusal Carious Molars Treated With Partial Caries Removal Technique
Nano silver fluoride solution, Cavity Cleanser - Dental Caries
Phase 3CompletedCairo University442018-04-012021-09-16
A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs
Abatacept, Placebo for abatacept (0.9% Sodium Chloride Injection or Solution for Infusion), Upadacitinib - Rheumatoid Arthritis (RA)
Phase 3CompletedAbbVie6572017-05-092024-07-18
A Study to Evaluate SAGE-217 in Participants With Severe Postpartum Depression
SAGE-217 15/20 mg Oral Solution, Placebo, SAGE 217 30 mg Capsules - Postpartum Depression
Phase 3CompletedBiogen2762017-01-042023-12-15

Showing 20 of 57. Sign in to see all of them.

Conditions studied

Ocular Hypertension (5)  ·  Alopecia (4)  ·  Glaucoma, Open-Angle (4)  ·  Pain, Postoperative (4)  ·  Primary Immunodeficiency Diseases (3)  ·  Anemia (2)  ·  Arthritis (2)  ·  COVID-19 (2)  ·  Foot Dermatoses (2)  ·  Keratoderma, Palmoplantar, Epidermolytic (2)  ·  Nails, Malformed (2)  ·  Onycholysis (2)  ·  Onychomycosis (2)  ·  Pain (2)  ·  Twenty-Nail Dystrophy (2)

Sponsors

Alcon Research (6)  ·  Baxalta now part of Shire (3)  ·  Pfizer (3)  ·  Cassiopea SpA (2)  ·  Merck Sharp & Dohme LLC (2)  ·  Sandoz (2)  ·  AbbVie (1)  ·  Allergan (1)  ·  Anthera Pharmaceuticals (1)  ·  Baxter Healthcare Corporation (1)  ·  Biogen (1)  ·  Biopharma Plasma LLC (1)  ·  Biosplice Therapeutics, Inc. (1)  ·  Cadence Pharmaceuticals (1)  ·  Cairo University (1)

Countries

United States (24)  ·  Canada (8)  ·  Germany (7)  ·  Poland (5)  ·  Spain (5)  ·  Brazil (4)  ·  France (4)  ·  Mexico (4)  ·  Belgium (3)  ·  Denmark (3)  ·  Hungary (3)  ·  Russia (3)  ·  South Korea (3)  ·  Turkey (Türkiye) (3)  ·  Ukraine (3)

Top investigators

Alessandro Mazzetti, M.D. (2)  ·  Andrea Vetter, Dr. (1)  ·  Anuj Bhatia, MD FRCPC (1)  ·  Arnaud Garnier, MD (1)  ·  Belaid BB Bouhemad, PU-PH (1)  ·  Benjamin BC Chousterman, PH (1)  ·  Bridgette L. Jones, MD (1)  ·  C Beausoleil (1)  ·  Catherine J Hardalo, MD (1)  ·  Claire CD Dahyot Fizelier, PU-PH (1)

Results publications

PMID 18538406, PMID 19194156, PMID 19365194, PMID 19668532, PMID 21656179, PMID 23960389, PMID 24643895, PMID 25365753, PMID 26060513, PMID 26214039, PMID 27007959, PMID 27418050, PMID 27459266, PMID 27582171, PMID 2788589, PMID 28871961, PMID 29300876, PMID 29408333, PMID 29897841, PMID 30626238, PMID 30886475, PMID 31136331, PMID 31228628, PMID 31268374, PMID 32040014, PMID 33212068, PMID 33693990, PMID 33774745, PMID 33781988, PMID 33822015, PMID 34003796, PMID 34036490, PMID 34190962, PMID 34219224, PMID 34219653, PMID 34305948, PMID 34767764, PMID 35123930, PMID 35659904, PMID 35751108, PMID 36715850, PMID 36724109, PMID 36729404, PMID 36754548, PMID 36803273, PMID 37303085, PMID 37308218, PMID 37945286, PMID 37982966, PMID 38125671

NIH funding

2019 (2), 2004 (1), 2005 (1), 2008 (1), 2009 (1), 2014 (1), 2015 (1), 2016 (1)